Vimarsana
Biggest News Aggregation in the World

Page 2 - Study Director News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Director Today - Breaking & Trending Today

Doxycycline taken after sex does not prevent bacterial STIs among cisgender women - Vimarsana News

Doxycycline taken after sex does not prevent bacterial STIs among cisgender women

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.

Global Clinical Sample Challenges — New Strategies for Molecular Testing & Flow Cytometry Panel Development, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Global Clinical Sample Challenges — New Strategies for Molecular Testing & Flow Cytometry Panel Development, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) February 13, 2023 -- Join this webinar to hear the featured speakers address global clinical sample challenges, with a focus on logistical

Source: prweb.com
BrainStorm Strengthens Executi - GuruFocus.com - Vimarsana News

BrainStorm Strengthens Executi - GuruFocus.com

GuruFocus Article or News written by PRNewswire and the topic is about:

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders - Vimarsana News

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders - read this article along with other careers information, tips and advice on BioSpace

BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal - Vimarsana News

BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced two...